Anti-biofilm Wound Dressing Market Report 2023: R&D Consistency Drives Sector Growth
Besides antimicrobial resistance and unhealthy sedentary
lifestyles, tobacco and alcohol consumption contribute to the rising
non-communicable disease burden. This is because chronic diseases such as
diabetes, cancer, and other autoimmune diseases become more prevalent.
There are also several other factors contributing to the
market's growth, including the development of healthcare infrastructure across
developing countries, and technological advancements in wound management. The efforts made by healthcare providers and
key players to make wound care more popular.
“Telehealth has played a key role in the strong
recovery of the wound care market. Various healthcare providers have developed
telehealth platforms to effectively manage patients with chronic and acute
wounds.” says a lead analyst at Future
Market Insights.
Key Takeaways from Market Study
·
The market for anti-biofilm wound dressing is
expected to record a CAGR of 9.5% over the forecast period.
·
According to estimates, the anti-biofilm wound
dressing market in North America may remain strong throughout the length of the
forecast period.
·
Acute wound segment dominated the market and is
expected to record a CAGR of 9.3%.
Competitive Landscape:
Several prominent companies dominate this market, including
ConvaTec, Smith & Nephew PLC, Urgo Medical, Coloplast, and 3M.
Anti-biofilm wound dressing has developed significantly in
the industry through partnerships, acquisitions, and research and development.
These strategies have resulted in major developments.
Get
More Insights@ https://www.futuremarketinsights.com/reports/anti-biofilm-wound-dressing-market
Anti-biofilm
Wound Dressing Market Segmentation by Category
By
Mode of Mechanism:
- Physical
- Chemical
- Biological
By
Wound Type:
- Chronic
Wounds
- Acute
Wounds
By End
User:
- Hospitals
and Clinics
- Surgical
Centers
- Other
End users
Comments
Post a Comment